The management of hypertriglyceridemia and the risk of pancreatitis

In the face of hypertriglyceridemia, the potential causes must be assessed to choose the best medical therapeutic option. In cases of secondary hypertriglyceridemia, physicians should use treatments targeting the pathophysiological mechanisms underlying the lipid disorder. Lifestyle interventions ar...

Full description

Saved in:
Bibliographic Details
Published inRevue médicale suisse Vol. 16; no. 684; p. 451
Main Authors Garelli, Valentina, Pauchet, Amélie, Kissling, Sébastien, Sartori, Claudio, Rodondi, Nicolas, Collet, Tinh-Hai
Format Journal Article
LanguageFrench
Published Switzerland 04.03.2020
Subjects
Acute Disease
Humans
Hypertriglyceridemia - complications
Hypertriglyceridemia - therapy
Insulin - administration & dosage
Insulin - therapeutic use
Pancreatitis - complications
Plasmapheresis
Online AccessGet full text

Cover

More Information
Summary:In the face of hypertriglyceridemia, the potential causes must be assessed to choose the best medical therapeutic option. In cases of secondary hypertriglyceridemia, physicians should use treatments targeting the pathophysiological mechanisms underlying the lipid disorder. Lifestyle interventions are the cornerstone of an effective treatment, to achieve controlled glycemia, blood pressure and weight loss. Only in cases where these measures are insufficient, fibrates can be trialed although their clinical benefit is controversial, with special caution when combined with statins (risk of rhabdomyolysis). Plasmapheresis or intravenous insulin therapy are only used in severe situations after a multidisciplinary decision process in the hospital setting. The clinical case presented here reminds us to assess hypertriglyceridemia in the face of any acute pancreatitis.
ISSN:1660-9379